Searched for
APTUIT LAURUS
Laurus Labs IPO gets subscribed 4.5 times on day 3The quota limit for qualified institutional buyers (QIB) category was subscribed 10.54 times, the retail individual investor (RII) category...
Laurus Labs IPO subscribed 61% on Day 2, QIB portion oversubscribedThe company intends to utilise the proceeds from the sale of fresh shares in the IPO to pre-pay term loans and for other general corporate ...
Laurus Labs IPO subscribed 28 per cent on Day 1; 10 things you must knowThe issue received bids for 62,09,420 shares as against 2,19,11,308 on offer, data available with the stock exchanges till 5 pm showed.
Rs 1,332 cr Laurus Labs IPO opens tomorrow, should you buy?Brokerage ICICI Securities believe at the upper end of the price band the stock is fairly priced, after considering the growth prospects, p...
Laurus Labs' Rs 1,332-crore IPO to hit market on TuesdayThe Hyderabad-based company plans to utilise the net proceeds from the fresh issue towards pre-payment of term loans and general corporate ...
Laurus Labs fixes IPO price band at Rs 426-428 a piece; issue opens on Dec 6The issue consists of an offer for sale (OFS) of 24,107,440 equity shares by existing shareholders Aptuit, Bluewater, FIL Capital Managemen...
Laurus Labs gets Rs 550-cr investment from Warburg PincusWhile core promoters of Laurus led by Dr Chava Satyanarayana own majority stake of over 51% in the company, PE investors and global pharmac...
- Fidelity Growth Partners invests Rs 200 crore in Aptuit Laurus
Fidelity Growth Partners India, the India-focused private equity arm of Fidelity Worldwide, has invested around Rs 200 crore in Aptuit Laur...
- Money inflow intact, 4 pharma FDI plans okayed
The Foreign Investment Promotion Board (FIPB) examines FDI proposals that are on the approval route, but in the case of pharmaceutical sect...
- Contract drug firm Aptuit to invest $ 100 mn
Global contract drug development firm Aptuit Inc and Hyderabad-based Laurus Labs Limited on Monday announced the formation of a contract dr...